181 related articles for article (PubMed ID: 21565283)
1. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease.
Ali RA; Dooley C; Comber H; Newell J; Egan LJ
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):584-9.e1-2. PubMed ID: 21565283
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer prognosis among patients with inflammatory bowel disease.
Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
[TBL] [Abstract][Full Text] [Related]
3. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of colorectal cancer in inflammatory bowel disease.
Bansal P; Sonnenberg A
Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH
Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662
[TBL] [Abstract][Full Text] [Related]
8. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
Bernstein CN; Nugent Z; Blanchard JF
Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathologic outcomes of colorectal cancer in a multi-ethnic population.
Koo JH; Kin S; Wong C; Jalaludin B; Kneebone A; Connor SJ; Leong RW
Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1016-21. PubMed ID: 18558515
[TBL] [Abstract][Full Text] [Related]
10. A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome.
Hrabe JE; Byrn JC; Button AM; Zamba GK; Kapadia MR; Mezhir JJ
J Surg Oncol; 2014 Feb; 109(2):117-21. PubMed ID: 24132737
[TBL] [Abstract][Full Text] [Related]
11. Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study.
Gearhart SL; Nathan H; Pawlik TM; Wick E; Efron J; Shore AD
Dis Colon Rectum; 2012 Mar; 55(3):270-7. PubMed ID: 22469793
[TBL] [Abstract][Full Text] [Related]
12. Improved survival in young women with colorectal cancer.
Koo JH; Jalaludin B; Wong SK; Kneebone A; Connor SJ; Leong RW
Am J Gastroenterol; 2008 Jun; 103(6):1488-95. PubMed ID: 18510616
[TBL] [Abstract][Full Text] [Related]
13. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
Bernstein CN; Blanchard JF; Metge C; Yogendran M
Am J Gastroenterol; 2003 Dec; 98(12):2784-8. PubMed ID: 14687833
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
15. Survival after colorectal cancer in patients with Crohn's disease: A nationwide population-based Danish follow-up study.
Larsen M; Mose H; Gislum M; Skriver MV; Jepsen P; Nørgård B; Sørensen HT
Am J Gastroenterol; 2007 Jan; 102(1):163-7. PubMed ID: 17037994
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention for colon cancer: new opportunities, fact or fiction?
Terhaar Sive Droste JS; Tuynman JB; Van Dullemen HM; Mulder CJ
Scand J Gastroenterol Suppl; 2006; (243):158-64. PubMed ID: 16782636
[TBL] [Abstract][Full Text] [Related]
17. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States.
Wang YR; Cangemi JR; Loftus EV; Picco MF
Am J Gastroenterol; 2013 Mar; 108(3):444-9. PubMed ID: 23295277
[TBL] [Abstract][Full Text] [Related]
18. High lifetime risk of cancer in primary sclerosing cholangitis.
Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR
J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
20. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.
Svrcek M; El-Bchiri J; Chalastanis A; Capel E; Dumont S; Buhard O; Oliveira C; Seruca R; Bossard C; Mosnier JF; Berger F; Leteurtre E; Lavergne-Slove A; Chenard MP; Hamelin R; Cosnes J; Beaugerie L; Tiret E; Duval A; Fléjou JF
J Clin Oncol; 2007 Sep; 25(27):4231-8. PubMed ID: 17878476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
